Tag:
Stalevo
Latest Headlines
Latest Headlines
FDA eyes safety of Novartis Parkinson's med
The FDA is looking into safety data on the Novartis drug Stalevo, a combination treatment for Parkinson's disease. The agency said the drug may increase the risk of heart attack, stroke and death in
FDA reviewing possible Stalevo-prostate cancer link
The FDA says it is evaluating clinical trial data that suggests that patients taking Stalevo, Novartis and Orion's Parkinson's disease treatment, may be at an increased risk for developing prostate
